Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Up – Still a Buy?

Shares of Ono Pharmaceutical Co. (OTCMKTS:OPHLF) gapped up prior to trading on Monday . The stock had previously closed at $13.50, but opened at $14.90. Ono Pharmaceutical shares last traded at $14.90, with a volume of 701 shares.

Analyst Ratings Changes

Separately, Zacks Research raised Ono Pharmaceutical to a “hold” rating in a report on Friday, April 17th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of “Hold”.

Ono Pharmaceutical Price Performance

The company has a market capitalization of $7.00 billion, a P/E ratio of 15.05 and a beta of 0.34. The company has a debt-to-equity ratio of 0.10, a current ratio of 3.02 and a quick ratio of 2.56. The firm’s 50-day moving average is $14.34 and its 200-day moving average is $14.58.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research‐based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.